We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.

Rose Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

FDA first amendment review

08 Jul 2002

News

Executive Summary

Deadline for submitting comments regarding FDA's regulation of commercial speech will be extended 45 days to Sept. 13, agency announces July 3. Public also will have additional 45 days to respond to comments of others with a deadline set for Oct. 28. Extension will be published in upcoming Federal Register notice, FDA says. Agency requested public comment on the constitutionality of its regulation of marketing and advertising of cosmetics, drugs and other products May 16 (1"The Rose Sheet" May 20, 2002, p. 7)...